Startup | September 29, 2021
Digital health-start-up MFine raises US $ 48 million
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions
The investment will increase SpeeDx internal capacity to scale up manufacturing
The company will leverage existing hospital and clinic partners’ infrastructure to build specialised `Experience Centres’ and facilitate a seamless, end-to-end secondary care surgery delivery. It will also offer healthcare financing
CuraTeQ Biologics is on track for filing a second oncology biosimilar
UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste
The initiative, with the support of MoHFW, will directly impact a population of more than 5.7 million that depend on the public health value chain across the 10 districts
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
RxDx is a chain of primary care driven multispecialty healthcare clinics with two main branches situated in Whitefield and Malleswaram in Bengaluru
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
Subscribe To Our Newsletter & Stay Updated
